Case Control Study
Copyright ©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Table 2 Plasma protein levels in different study groups

Control (n = 30)
Benign (n = 10)
Malignant (n = 50)
P value
Cancer antigen 125 (U/mL)12.2 (3.1-25.9)a28.6 (3.5-1217)b232 (5.5-3649)c< 0.001
Human epididymis protein 4 (pmol/L)41.6 (3.8-83.8)a93.4 (37-800)b283 (37-5908)b< 0.001
Insulin-like growth factors-binding proteins 2 (pg/mL)273 (117-353)a2641 (1114-3773)b2669 (146-5785)b< 0.001
Thrombospondin 1 protein (pg/mL)2899 (95-8500)1702 (560-3540)1803 (92-8500)0.051
Secreted phosphoprotein 1 (ng/mL)4.2 (1.9-6.3)a3.98 (0.85-11.5)a40.4 (11-76.5)b< 0.001
D-dimer (ng/mL)0.1 (0-0.5)a832 (262-3429)b744 (50-1000)b< 0.001